|
Treating Thought Problems in Patients with Schizophrenia Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, trips or professional assistance with a real medical doctor. We aren't docs. Always confer with your doctor about Treating Thought Problems in Patients with Schizophrenia conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Treating Thought Problems in Patients with Schizophrenia Clinical research trials and Treating Thought Problems in Patients with Schizophrenia health trials happen in many of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectualness of new does drugs. The intention of the studies / projects is to figure out particular human healthcare questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to detect cures for all forms of circumstances, like Treating Thought Problems in Patients with Schizophrenia. Treating Thought Problems in Patients with Schizophrenia Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment options before they are available to the general public. Most times the subjects get treatment for free of charge, and occasionally they are paid for their time. Occasionally there is a cost for a Treating Thought Problems in Patients with Schizophrenia clinical trial. Subjects frequently get the best healthcare possible for their Treating Thought Problems in Patients with Schizophrenia condition. Hazards are a reality, however, and could include more or frequent mD visits, health risks (possibly life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "T" Clinical Trials Conditions > Treating Thought Problems in Patients with Schizophrenia  Treating Thought Problems in Patients with Schizophrenia
Treating Thought Problems in Patients with Schizophrenia
For Condition: Schizophrenia
Status: Recruiting
Sponsor(s): National Institute of Mental Health (NIMH) ,
Synopsis: The purpose of this study is to compare Cognitive Adaptation Training (CAT) to minimal schizophrenia treatment. This study will also determine whether the intensity of CAT can be reduced and still provide benefits to patients with schizophrenia.
Details: Many schizophrenia patients have serious difficulties that affect their quality of life. Cognitive Adaptation Training (CAT) may improve adaptive functioning, quality of life, and rates of relapse in schizophrenia patients. CAT, which involves compensatory strategies or environmental supports, is tailored to each individual and is based on executive functioning levels and other factors. Participants are randomly assigned to CAT, Minimal Environmental Supports (MES), or treatment as usual for 2 years. Participants receiving CAT will have a trained therapist make weekly visits to their home for 9 months. Over the following 3 months, the frequency of CAT visits will be slowly reduced to once a month. For the remaining 12 months of treatment, patients receive CAT only once a month. Participants assigned to the MES group receive a generic set of supplies and equipment (calendar, alarm clock, watch, bus passes, etc.) at the beginning of the 2-year period. Each month, the supplies are replenished as necessary during the patient's scheduled clinic visit. In all groups, assessments of adaptive function and quality of life occur at study start and at 3, 6, 9, 18, and 24 months.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Single Blind, Placebo Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: 18 Years/60 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - DSM-IV diagnosis of schizophrenia or schizoaffective disorder - Treatment with an atypical antipsychotic medication - Stable living environment - Able to read, understand, and complete rating scales and neuropsychological testing - Willing to participate in psychosocial treatments for schizophrenia that may involve home visits Exclusion Criteria: - History of significant head trauma, seizure disorder, or mental retardation - Alcohol or drug abuse that could interfere with participation in the study - Treatment by an ACT team - History of violence in the past year - Score > 80 on the SOFAS - Hospitalized in the past year
Total Enrollment: 120
Location and Contact Information:
Overall Study Official:
DawnVelligan, Principal Investigator, University of Texas
University of Texas Health Science Center at San Antonio *Recruiting*
San Antonio, Texas, 78229
United States
Recruiting Natalie Maples 210-531-8122
Additional Information:
Study ID Numbers: 61775-01A2;
Study Start Date: February 2002
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00051740
Other Schizophrenia Studies:
1. Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)
2. Eye Blink Response in Healthy Volunteers and Adults with Schizophrenia
3. Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia
4. Treatment for First-Episode Schizophrenia
5. Glucose regulation during risperidone and olanzapine treatment
Related Studies:
Other Schizophrenia Clinical Trials
Other Texas Clinical Trials
Other San Antonio Clinical Trials
Treating Thought Problems in Patients with Schizophrenia
|
|
|
|
|
|
|
|
